Cochrane Abstracts
Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Regular Treatment With Formoterol and an Inhaled Corticosteroid Versus Regular Treatment With Salmeterol and an Inhaled Corticosteroid for Chronic Asthma: Serious Adverse Events." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431882/1/Regular_treatment_with_formoterol_and_an_inhaled_corticosteroid_versus_regular_treatment_with_salmeterol_and_an_inhaled_corticosteroid_for_chronic_asthma:_serious_adverse_events.
Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431882/1/Regular_treatment_with_formoterol_and_an_inhaled_corticosteroid_versus_regular_treatment_with_salmeterol_and_an_inhaled_corticosteroid_for_chronic_asthma:_serious_adverse_events. Accessed December 3, 2024.
Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431882/1/Regular_treatment_with_formoterol_and_an_inhaled_corticosteroid_versus_regular_treatment_with_salmeterol_and_an_inhaled_corticosteroid_for_chronic_asthma:_serious_adverse_events
Regular Treatment With Formoterol and an Inhaled Corticosteroid Versus Regular Treatment With Salmeterol and an Inhaled Corticosteroid for Chronic Asthma: Serious Adverse Events [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431882/1/Regular_treatment_with_formoterol_and_an_inhaled_corticosteroid_versus_regular_treatment_with_salmeterol_and_an_inhaled_corticosteroid_for_chronic_asthma:_serious_adverse_events.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events
ID - 431882
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431882/1/Regular_treatment_with_formoterol_and_an_inhaled_corticosteroid_versus_regular_treatment_with_salmeterol_and_an_inhaled_corticosteroid_for_chronic_asthma:_serious_adverse_events
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
